Cancer Suicide Gene Therapy with TK.007

Area of Science:

• Oncology
• Gene Therapy
• Molecular Biology

Background:

• Cancer is characterized by uncontrolled cell growth, necessitating innovative therapeutic strategies.
• Suicide gene therapy (SGT) induces cancer-specific cell death and shows promise in various cancer types.
• SGT is also explored as a safeguard in adoptive immunotherapy and regenerative medicine.

Purpose of the Study:

• To provide a framework of protocols for basic and translational research in SGT.
• To detail the Herpes-simplex-virus thymidine kinase (HSV-TK)/ganciclovir (GCV) system, a prominent SGT method.
• To establish guidelines for lentiviral vector preparation and application in cancer treatment.

Main Methods:

• Development of protocols for lentiviral vector production.
• Preparation of high-titer third-generation lentiviral vectors encoding an improved HSV-TK variant (TK.007).
• Application of the HSV-TK/GCV system in in vitro and in vivo cancer models.

Main Results:

• Established guidelines for generating lentiviral vectors for SGT.
• Demonstrated the application of the TK.007 gene in cancer treatment setups.
• Provided a framework for research utilizing the HSV-TK/GCV suicide gene therapy approach.

Conclusions:

• The HSV-TK/GCV system, particularly with the TK.007 variant, offers a viable strategy for cancer therapy.
• Standardized protocols facilitate research and translation of SGT for cancer treatment.
• SGT holds significant potential as a therapeutic modality for various cancers.